REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Consult Bulgaria OOD (Bulgaria)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharma Consult Bulgaria OOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Pharma Consult Bulgaria OOD is a company based in Bulgaria, with its head office in Sofia. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on 2012. 3 (2023) employees currently work for Pharma Consult Bulgaria OOD. From the latest financial highlights, Pharma Consult Bulgaria OOD reported a net sales revenue drop of 22.22% in 2022. A growth of 5.77% was recorded in its total assets. The net profit margin of Pharma Consult Bulgaria OOD decreased by 2.55% in 2022.

Headquarters
Zh.k.gorna Banya Vechernitsa 16
Sofia; Sofia - city; Postal Code: 1614

Contact Details: Purchase the Pharma Consult Bulgaria OOD report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Consult Bulgaria OOD report to view the information.
Outstanding Shares:
Purchase the Pharma Consult Bulgaria OOD report to view the information.
Registered Capital:
Purchase the Pharma Consult Bulgaria OOD report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Pharma Consult Bulgaria OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-22.22%
Total operating revenue
-21.61%
Operating profit (EBIT)
2204.83%
EBITDA
2001.69%
Net Profit (Loss) for the Period
-91.23%
Total assets
5.77%
Total equity
6.94%
Operating Profit Margin (ROS)
97.38%
Net Profit Margin
-2.55%
Return on Equity (ROE)
-72.68%
Quick Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?